Related Experiment Video
Updated: Aug 13, 2026

06:56
A System for Culturing Iris Pigment Epithelial Cells to Study Lens Regeneration in Newt
Published on: June 22, 2011
Artificial iris-lens diaphragm in reconstructive surgery for aniridia and aphakia
Nadezhda A Pozdeyeva1, Nikolay P Pashtayev, Vladislav P Lukin
1Svyatoslav Fyodorov MNTK Eye Microsurgery, Cheboksary, Russia. npozd@chebnet.com
Journal of Cataract and Refractive Surgery
|October 26, 2005
Summary
Artificial iris-lens diaphragm implantation improved vision and cosmetic outcomes for patients with iris deficiencies, aphakia, or cataracts. While generally safe, further studies are needed to confirm long-term efficacy and safety.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Surgical Innovation
Background:
- Iris deficiencies, aphakia, and cataracts significantly impact visual function and quality of life.
- Existing treatments for iris and lens pathology may have limitations in addressing both functional and cosmetic concerns.
Purpose of the Study:
- To evaluate the efficacy and safety of surgically implanted artificial iris-lens diaphragms.
- To assess the device's utility in patients with iris deficiencies, aphakia, or cataracts.
Main Methods:
- An interventional case series involving 19 patients (20 eyes) with traumatic or congenital iris and lens pathology.
- Implantation of a novel elastic iris-lens diaphragm with various fixation techniques.
Main Results:
- 75% of eyes showed improved corrected visual acuity; all patients reported satisfaction with cosmetic results and reduced glare/photophobia.
- Complications included vitreous hemorrhage, hyphema, ciliochoroidal detachment, and inflammation; no device decentration or retinal detachment occurred.
- One case of persistent intraocular pressure rise and one of cystoid macular edema were noted.
Conclusions:
- Artificial iris-lens diaphragm implantation is effective in improving visual outcomes and addressing cosmetic deficits in relevant patient populations.
- The device appears safe, but long-term efficacy and safety require further investigation with larger cohorts and extended follow-up.

